Research shows that Biotechnology companies have been facing significant challenges – with continual declines in deal making activity and the concentration of limited funding opportunities. For these reasons, there has been increased demand for outsourcing trials to lower the barrier of entry into the clinic.
Australia continues to solidify its position as a leading destination for supporting clinical development, providing a pathway for improved data quality while minimizing time and cost barriers. Agilex recently collaborated with industry experts to record an impactful webinar with the aim of providing sponsors with an edge on understanding the Australian solution, carefully calling out the key advantages that our existing sponsors leverage in Australia.
What you’ll hear about in this webinar:
- High-Quality Data – Understand why Australian data is globally accepted by the FDA, EMA, and other regulators, backed by world-class institutions and stringent quality management systems.
- Speed & Efficiency – Learn how the streamlined regulatory process works, and why it means trials can start within 4-6 weeks of submission, without compromising rigor.
- Cost-Effective Solutions – Hear about how you can leverage from significant savings through Australia’s generous R&D tax incentive, reducing trial costs by up to 43.5%.
Presenters
Join Agilex Biolabs, Southern Star Research, Nucleus Network, RDI Partners, Scendea and IDT Australia and also discover how our collaboration offers a turnkey solution on delivering a clinical trial in Australia.
Don’t miss your chance – enter your details below to access the webinar and gain the edge!
